CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to TXMD

DPI-386 Nasal Gel

Phase 3
TherapeuticsMD, Inc. (TXMD)

Phase 3

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Sep '26
TXMDPhase 2

DPI-386 Nasal Gel Phase 2 Est. Readout

DPI-386 Nasal Gel
Sep 2026~STALE
CT.gov
00%
Competitive Landscape

0 competitors in Motion Sickness, Space

View Full Landscape
Drug Information

Target Indication

Motion Sickness, Space

Clinical Trial

NCT05852730

Last updated: 7/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.